首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2350866篇
  免费   171263篇
  国内免费   3331篇
耳鼻咽喉   32059篇
儿科学   75904篇
妇产科学   62696篇
基础医学   348259篇
口腔科学   63649篇
临床医学   211409篇
内科学   457461篇
皮肤病学   51731篇
神经病学   185324篇
特种医学   88015篇
外国民族医学   489篇
外科学   354013篇
综合类   47512篇
现状与发展   12篇
一般理论   848篇
预防医学   182757篇
眼科学   54326篇
药学   175126篇
  11篇
中国医学   4575篇
肿瘤学   129284篇
  2021年   18984篇
  2019年   19549篇
  2018年   27075篇
  2017年   20368篇
  2016年   22753篇
  2015年   25650篇
  2014年   36113篇
  2013年   53974篇
  2012年   74699篇
  2011年   79438篇
  2010年   47077篇
  2009年   44585篇
  2008年   74638篇
  2007年   79511篇
  2006年   80330篇
  2005年   77815篇
  2004年   74401篇
  2003年   71719篇
  2002年   69397篇
  2001年   108756篇
  2000年   111471篇
  1999年   93505篇
  1998年   26998篇
  1997年   23664篇
  1996年   24061篇
  1995年   22721篇
  1994年   20897篇
  1993年   19715篇
  1992年   72010篇
  1991年   70081篇
  1990年   68405篇
  1989年   65675篇
  1988年   60312篇
  1987年   59135篇
  1986年   55228篇
  1985年   53013篇
  1984年   39319篇
  1983年   33402篇
  1982年   19860篇
  1979年   35875篇
  1978年   25657篇
  1977年   21232篇
  1976年   20336篇
  1975年   21819篇
  1974年   26152篇
  1973年   24806篇
  1972年   23208篇
  1971年   22043篇
  1970年   20256篇
  1969年   19321篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
Graefe's Archive for Clinical and Experimental Ophthalmology - The published online version contains mistake as the author's first name and last name have been interchanged as "Hild...  相似文献   
13.
14.
15.
The purpose of this investigation was to characterize noise levels in spaces designated as “effective quiet” areas on a U.S. Navy aircraft carrier. Noise dosimetry samples were collected in 15 designated spaces, representing 15 noise measurements, while at-sea during airwing carrier qualifications. Equivalent sound level (Leq) measurements were collected during flight operations (Leq (flt ops)), non-flight operations (Leq (non-flt ops)), and over 24-hr periods (Leq (24-hr)). These data were compared to the 70 dBA American Conference of Governmental Industrial Hygienists (ACGIH®) Threshold Limit Value (TLV®) for “effective quiet” areas intended for temporary threshold shift recovery when personnel live and work in a potentially noise hazardous environment for periods greater than 24?hr. The monitored areas were selected based on personnel occupancy/use during off-duty time periods. Areas were classified by either (1) leisure areas that included mess (eating areas), gyms, lounges, an internet cafe, and the fantail social area or (2) berthing (sleeping) areas. The Leq measurements in decibels “A” weighted (dBA) were compared to determine significant differences between Leq (flt ops), Leq (non-flt ops), and Leq (24-hr) and were compared between leisure area and berthing area. Measured noise levels according to time period ranged as follows: (1) Leq (24-hr): 70.8–105.4 dBA; (2) Leq (flt ops): 70–101.2 dBA; and (3) Leq (non-flt ops): 39.4–104.6 dBA. All area measurements over the 24-hr period and during flight operations and 46.7% of the areas during the non-flight operation time period exceeded the “effective quiet” 70 dBA ACGIH TLV. Mean Leqs were 15 dBA higher during flight operations compared to non-flight operations in “effective quiet” areas (p?=?0.001). The Leqs in leisure areas were significantly higher than berthing areas by approximately 21 dBA during non-flight operation periods (p?=?0.001). Results suggest noise levels in “effective quiet” areas frequented by aircraft carrier personnel during off-duty hours when at-sea may inhibit auditory recovery from occupational noise exposures that occur on-duty.  相似文献   
16.
17.
18.
Pharmaceutical Chemistry Journal - An HPLC-MS method for simultaneous quantitative determination of a novel gestagenic pharmaceutical and two of its metabolites in rat and rabbit blood sera was...  相似文献   
19.
Bulletin of Experimental Biology and Medicine - Ammonium, an end-product of catabolism, in low doses can promote adaptation of metabolic pathways in erythrocytes under conditions of extreme...  相似文献   
20.
Introduction: Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype associated with an increased risk of recurrence and cancer-related death. Unlike hormone receptor-positive or HER2-positive breast cancers, there are limited targeted therapies available to treat TNBC and cytotoxic chemotherapy remains the mainstay of treatment. Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate targeting Trop-2 expressing cells and selectively delivering SN-38, an active metabolite of irinotecan.

Areas covered: This review covers the mechanism of action, safety and efficacy of sacituzumab govitecan in patients with previously treated, metastatic TNBC. Additionally, efficacy data in other epithelial malignancies is included based on a PubMed search for ‘sacituzumab govitecan’ and ‘clinical trial’.

Expert opinion: Sacituzumab govitecan has promising anti-cancer activity in patients with metastatic TNBC previously treated with at least two prior lines of systemic therapy based on a single arm Phase I/II clinical trial. A confirmatory Phase III randomized clinical trial is ongoing. Sacituzumab govitecan has a manageable side effect profile, with the most common adverse events being nausea, neutropenia, and diarrhea. The activity of sacituzumab govitecan likely extends beyond TNBC with promising early efficacy data in many other epithelial cancers, including hormone receptor-positive breast cancer.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号